ARCHIVES

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

This article is from The Cancer Letter archive.

Vol. 34 No. 38 | October 17, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

March 23, 1990

NIGMS Awards First Grants For Gene Mapping

August 19, 1988

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

Novel Agents Promise Relief From Hematologic Side Effects

July 27, 2001

Acting NIH Director Says M.D. Anderson President John Mendelsohn Outlines 10-Point Plan For Cancer Research

February 20, 2009

Community Assn. Plan Meeting In DC On Program Problems

November 29, 1974